-
June 11, 2013
With Xenon exercising its option, Isis Pharma is entitled to receive $2 million from Xenon.
-
May 28, 2013
Alnylam has already seen a big run, but clinical success could bring even more gains.
-
January 30, 2013
The US Food and Drug Administration (FDA) recently approved Kynamro (mipomersen sodium) injection developed by ...
-
January 14, 2013
Aegerion Pharmaceuticals, Inc. (AEGR) recently provided more details on its public offering. The offering is ...
-
January 11, 2013
Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
-
January 11, 2013
Aegerion Pharmaceuticals, Inc. (AEGR) recently announced its intention to raise funds through the issuance of its ...
-
January 08, 2013
Aegerion Pharmaceuticals Inc. (AEGR) recently announced its 2013 guidance as the company prepares for the launch of ...
-
December 26, 2012
The US Food and Drug Administration (FDA) recently approved Aegerion Pharmaceuticals' (AEGR) Juxtapid (lomitapide) ...
-
December 17, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
December 17, 2012
On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up ...
-
December 14, 2012
Isis Pharmaceuticals Inc. (ISIS) and AstraZeneca (AZN) recently announced that they have entered into an agreement ...
-
November 07, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently amended its deal with GlaxoSmithKline (GSK) for the development of their ...
-
November 07, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a adjusted net loss of 33 cents per share in the third quarter of 2012, ...
-
November 07, 2012
Alnylam Pharmaceuticals Inc.'s (ALNY) third quarter 2012 net loss of 38 cents per share was wider than the year-ago ...
-
November 05, 2012
Isis Pharmaceuticals Inc. (ISIS) recently announced that Pfizer Inc. (PFE) will move EXC 001 (also known as as ...
-
October 26, 2012
Sanofi (SNY) reported third quarter 2012 business earnings of $1.05 per American Depositary Share (ADS), much lower ...
-
October 22, 2012
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee recently voted in ...
-
October 17, 2012
In its briefing document, the US Food and Drug Administration (FDA) recently raised issues regarding the safety of ...
-
October 17, 2012
The Nasdaq has remained steady, the S&P 500 is up 0.3% and the Dow remains relatively unchanged so far today. The ...
-
October 16, 2012
The market is having a good day so far: the Nasdaq has increased 1.1%; the S&P 500 has risen 1%; and the Dow is ...
